ALBANY, N.Y., Jan. 15, 2013 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced that it will host an investor and analyst meeting on Wednesday, January 23, 2013, to discuss AngioDynamics' long-term growth strategy, research and development pipeline, and financial outlook. The day will also include a technology fair and product demonstrations.
The program will include presentations by AngioDynamics' President and Chief Executive Officer Joseph DeVivo and Executive Vice President and Chief Financial Officer Mark Frost, as well as presentations and question and answer with members of the senior management team.
Advanced registration is required, and attendance will be limited to institutional investors and equity research analysts who register in advance. To register for the meeting, please contact the Company's Investor Relations: Greg Gin of EVC Group, Inc. at ggin@evcgroup.com.
A live webcast will be available at http://investors.angiodynamics.com. A replay and the presentation materials will be available at the same website following the conclusion of the meeting.
About AngioDynamics
AngioDynamics Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology. AngioDynamics' diverse product lines include market-leading ablation systems, fluid management systems, vascular access products, angiographic products and accessories, angioplasty products, drainage products, thrombolytic products and venous products. More information is available at www.AngioDynamics.com.
Trademarks
AngioDynamics and the AngioDynamics logo are trademarks and/or registered trademarks of AngioDynamics Inc., an affiliate or a subsidiary.
CONTACT: Company Contact:
AngioDynamics, Inc.Mark Frost, CFO
(800) 772-6446 x1981
mfrost@AngioDynamics.com
Investor Relations Contacts:
EVC Group, Inc.Greg Gin/Robert Jones
(646) 445-4801; (646) 201-5447
ggin@evcgroup.com; bjones@evcgroup.com
Media Contact:
EVC Group, Inc.Chris Gale
(646) 201-5431
cgale@evcgroup.com
Source:
AngioDynamics
News Provided by Acquire Media